These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 27152654)
1. Drug coated balloon angioplasty in the treatment of peripheral artery disease. Colleran R; Harada Y; Cassese S; Byrne RA Expert Rev Med Devices; 2016 Jun; 13(6):569-82. PubMed ID: 27152654 [TBL] [Abstract][Full Text] [Related]
2. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854 [TBL] [Abstract][Full Text] [Related]
3. The evolving role of drug-coated balloons for the treatment of complex femoropopliteal lesions. Korosoglou G; Lichtenberg M; Celik S; Andrassy J; Brodmann M; Andrassy M J Cardiovasc Surg (Torino); 2018 Feb; 59(1):51-59. PubMed ID: 28975777 [TBL] [Abstract][Full Text] [Related]
4. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Tepe G; Laird J; Schneider P; Brodmann M; Krishnan P; Micari A; Metzger C; Scheinert D; Zeller T; Cohen DJ; Snead DB; Alexander B; Landini M; Jaff MR; Circulation; 2015 Feb; 131(5):495-502. PubMed ID: 25472980 [TBL] [Abstract][Full Text] [Related]
6. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents? Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201 [TBL] [Abstract][Full Text] [Related]
7. Standard balloon angioplasty versus angioplasty with paclitaxel-eluting balloons for femoropopliteal artery stenosis. Ju MH; Rodríguez HE J Cardiovasc Surg (Torino); 2012 Aug; 53(4):459-63. PubMed ID: 22854525 [TBL] [Abstract][Full Text] [Related]
8. Critical limb ischemia update and the evolving role of drug-elution technologies. Hooker JB; Hawkins BM Expert Rev Cardiovasc Ther; 2017 Dec; 15(12):891-896. PubMed ID: 29157024 [TBL] [Abstract][Full Text] [Related]
9. Monitoring of gadolinium-BOPTA uptake into the vessel wall during magnetic resonance (MR)-guided angioplasty of the peripheral arteries with a paclitaxel/gadolinium-BOPTA-coated balloon: an experimental study at 3 Tesla. Neizel M; Ruebben A; Weiss N; Günther RW; Kelm M; Krombach GA Rofo; 2014 Apr; 186(4):388-93. PubMed ID: 24142436 [TBL] [Abstract][Full Text] [Related]
10. [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence]. Herten M; Stahlhoff S; Imm B; Schönefeld E; Schwindt A; Torsello GB Radiologe; 2016 Mar; 56(3):240-53. PubMed ID: 26885653 [TBL] [Abstract][Full Text] [Related]
11. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749 [TBL] [Abstract][Full Text] [Related]
12. Promising role of drug-coated balloons in the tibial vessels? Langhoff R; Behne A; Buschmann E J Cardiovasc Surg (Torino); 2016 Oct; 57(5):667-76. PubMed ID: 27465390 [TBL] [Abstract][Full Text] [Related]
13. Drug-coated balloons and their place in treating peripheral arterial disease. Schnorr B; Albrecht T Expert Rev Med Devices; 2013 Jan; 10(1):105-14. PubMed ID: 23278227 [TBL] [Abstract][Full Text] [Related]
15. The role for DCBs in the treatment of ISR. Bague N; Nasr B; Chaillou P; Costargent A; Gouailler-Vulcain F; Goueffic Y J Cardiovasc Surg (Torino); 2016 Aug; 57(4):578-85. PubMed ID: 27102629 [TBL] [Abstract][Full Text] [Related]
16. Peripheral applications of drug-coated balloons: past, present and future. Krokidis M; Spiliopoulos S; Katsanos K; Sabharwal T Cardiovasc Intervent Radiol; 2013 Apr; 36(2):281-91. PubMed ID: 22915325 [TBL] [Abstract][Full Text] [Related]
17. Local delivery of paclitaxel in the treatment of peripheral arterial disease. Ng VG; Mena C; Pietras C; Lansky AJ Eur J Clin Invest; 2015 Mar; 45(3):333-45. PubMed ID: 25615282 [TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Cassese S; Byrne RA; Ott I; Ndrepepa G; Nerad M; Kastrati A; Fusaro M Circ Cardiovasc Interv; 2012 Aug; 5(4):582-9. PubMed ID: 22851526 [TBL] [Abstract][Full Text] [Related]
19. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811 [TBL] [Abstract][Full Text] [Related]
20. Drug eluting devices for critically ill patients: can we apply lessons learned from the treatment of peripheral artery disease? Werner M; Scheinert D Adv Drug Deliv Rev; 2014 Nov; 77():32-9. PubMed ID: 25049084 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]